← Back to headlines
Eli Lilly and InSilico Partner on AI Drug Discovery
Pharmaceutical giant Eli Lilly has finalized a deal with InSilico, a company specializing in artificial intelligence, to collaborate on drug discovery efforts.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
'Astronauts back on Earth': Artemis II crew splashes down after record-breaking moon flyby – video
just now
Climate Scientists Warn of Impending Funding Shortage for Extreme Weather Research
22m ago
Study Reveals Unexpected Grooves Form When Crushing Beverage Cans
24m ago
Prehistoric children’s remains show syphilis-like disease spread through ancient Vietnam - study
32m ago